ResMed Competitors

Stocks . USA . 
Stock . ResMed Inc
RMD Stock  USD 245.73  13.29  5.13%   
ResMed Inc competes with Alcon AG, IQVIA Holdings, Humana, GE HealthCare, and Agilent Technologies; as well as few others. The company runs under Health Care Equipment & Supplies sector within Health Care industry. Analyzing ResMed competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of ResMed to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out ResMed Correlation with its peers.

ResMed vs Insmed Correlation

Very good diversification

The correlation between ResMed Inc and INSM is -0.48 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ResMed Inc and INSM in the same portfolio, assuming nothing else is changed.

Moving against ResMed Stock

  0.66XTNT Xtant Medical HoldingsPairCorr
  0.53HAE HaemoneticsPairCorr
  0.52AHC Austco HealthcarePairCorr
  0.43OTC Ocumetics Technology CorpPairCorr
  0.33RHT Resonance HealthPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
248.20249.73251.26
Details
Intrinsic
Valuation
LowRealHigh
223.60275.61277.14
Details

ResMed Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between ResMed and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of ResMed and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of ResMed Inc does not affect the price movement of the other competitor.

High positive correlations

HLN
+ 0.8
BDX
GEHC
+ 0.66
ALC
MTD
+ 0.62
IQV
MTD
+ 0.55
A
INSM
+ 0.55
A
HLN
+ 0.55
CAH
  

High negative correlations

INSM
- 0.82
HLN
INSM
- 0.8
BDX
CAH
- 0.65
HUM
HLN
- 0.53
IQV
HLN
- 0.52
HUM
INSM
- 0.5
CAH

Risk-Adjusted Indicators

There is a big difference between ResMed Stock performing well and ResMed Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ResMed's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ALC  1.09 (0.03)(0.04) 0.03  1.16 
(1.26)
 2.60 
(1.98)
 7.05 
IQV  1.66 (0.51) 0.00 (0.28) 0.00 
 0.00 
 3.30 
(4.70)
 15.97 
HUM  2.12 (0.56) 0.00 (0.32) 0.00 
 0.00 
 3.79 
(5.40)
 27.31 
GEHC  1.48  0.06  0.03  0.13  1.74 
(1.50)
 3.38 
(2.77)
 7.77 
A  1.25 (0.33) 0.00 (0.18) 0.00 
 0.00 
 2.90 
(2.73)
 7.85 
MTD  1.14 (0.12) 0.00 (0.05) 0.00 
 0.00 
 2.51 
(2.37)
 7.69 
BDX  1.19  0.21  0.19  0.33  0.73 
(1.50)
 3.22 
(1.77)
 7.13 
CAH  1.08  0.11  0.01 (0.42) 1.44 
(1.18)
 1.94 
(2.43)
 12.26 
HLN  0.97  0.24  0.16  1.82  0.83 
(1.12)
 2.76 
(1.65)
 5.40 
INSM  1.89 (0.41) 0.00  1.89  0.00 
 0.00 
 2.84 
(4.15)
 20.19 

ResMed Competitive Analysis

The better you understand ResMed competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, ResMed's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across ResMed's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
RMD ALC IQV HUM GEHC A MTD BDX CAH HLN
 5.13 
 245.73 
ResMed
 1.06 
 78.55 
Alcon
 4.70 
 168.85 
IQVIA
 1.96 
 178.83 
Humana
 0.69 
 78.65 
GEHC
 3.12 
 124.88 
Agilent
 2.49 
 1,358 
Mettler
 1.56 
 177.81 
Becton
 4.10 
 215.06 
Cardinal
 1.09 
 11.16 
Haleon
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Mild
Weak
Weakest
Weakest
Mild
Weakest
Weakest
Weakest
Fair
Solid
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Tiny
Small
Low
Low
Low
Tiny
Tiny
Low
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Fairly Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Buy
Not Available
Buy
Not Available
Not Available
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Strong Hold
Strong Hold
Sell
Strong Hold
Strong Hold
Strong Hold
Hold
Hold
Strong Buy
Current Ratio
2.8
2.16
0.9
1.53
N/A
2.03
1.13
1.35
1.04
3.43
Net Asset
8.17 B
30.35 B
29.94 B
46.48 B
36.91 B
12.73 B
3.71 B
55.33 B
53.12 B
34.31 B
Profit Margin
0.28
0.1
0.0834
0.0092
0.1
0.19
0.22
0.0801
0.0068
0.14
EBITDA
1.91 B
2.68 B
3.46 B
2.77 B
3.79 B
1.83 B
1.23 B
4.96 B
3.11 B
2.51 B
Operating Margin
0.35
0.13
0.15
-0.0249
0.16
0.26
0.31
0.13
0.0123
0.22
Current Valuation
37.82 B
41.87 B
44.75 B
28.31 B
42.01 B
36.89 B
30.55 B
67.65 B
58.08 B
58.14 B
Price To Book
6.07
1.68
4.76
1.14
3.47
5.24
3980.99
1.93
16.07
2.27
Retained Earnings
6.08 B
28.5 M
7.42 B
28.32 B
5.28 B
1.39 B
9.24 B
16.62 B
783 M
27.27 B
Current Asset
1.42 B
33.24 M
2.28 B
2.76 B
N/A
3.63 B
862.82 M
6.37 B
21.96 B
N/A
Five Year Return
1.02
N/A
N/A
0.64
N/A
0.73
N/A
1.29
3.61
N/A
Beta
0.88
0.69
1.36
0.44
1.23
1.3
1.44
0.28
0.66
0.22
Number Of Employees
10.6 K
25 K
93 K
65.68 K
54 K
18.1 K
16.6 K
70 K
53.08 K
24.56 K
Shares Outstanding
145.68 M
491.2 M
169.6 M
120.27 M
455.75 M
282.84 M
20.33 M
284.63 M
235.32 M
4.45 B
Cash Flow From Operations
1.75 B
2.08 B
2.65 B
921 M
1.99 B
1.56 B
955.77 M
3.43 B
2.4 B
2.3 B
Annual Yield
0.0091
0.0041
N/A
0.0202
0.0018
0.0079
N/A
0.0245
0.0093
0.0167
Total Debt
851.81 M
5.14 B
16.17 B
11.14 B
10 B
3.35 B
2.34 B
19.18 B
9.35 B
10.1 B
Return On Equity
0.26
0.0482
0.21
0.0704
0.22
0.21
0.3
0.0696
N/A
0.0938
Return On Asset
0.15
0.0262
0.0503
0.0354
0.0547
0.0849
0.2
0.0405
0.035
0.0461
Number Of Shares Shorted
11.12 M
6.71 M
4.56 M
5.85 M
9.97 M
4.28 M
537.62 K
6.69 M
5.09 M
17.84 M
Book Value Per Share
43.39
44.96
38.34
146.42
22.77
23.82
-1.16
88.79
-12.22
2.41
Current Liabilities
637.99 M
182.23 M
1.91 B
2.39 B
N/A
945 M
595.13 M
4.4 B
19.7 B
N/A
Total Asset
8.17 B
30.35 B
29.94 B
46.48 B
36.91 B
12.73 B
3.71 B
55.33 B
53.12 B
34.31 B
Debt To Equity
0.27
0.22
2.37
0.85
N/A
0.52
N/A
0.64
5.63
0.38
Short Ratio
11.31
5.67
3.85
2.99
3.02
2.19
4.2
3.91
3.02
2.27
Target Price
297.47
91.8
246.1
248.91
93.25
169.67
1501.38
195.38
247.8
11.82
Last Dividend Paid
2.26
0.31
N/A
N/A
0.14
0.99
N/A
4.17
2.04
0.068
Shares Owned By Institutions
66.74
68.0
99.01
99.8
89.47
93.48
99.56
95.51
93.95
12.35
Market Capitalization
38.47 B
39.68 B
30.17 B
21.51 B
36.1 B
35.4 B
28.61 B
65.44 B
52.77 B
49.16 B
Price To Earning
73.48
62.6
103.68
19.12
N/A
37.55
38.4
45.86
16.0
18.06
Price To Earnings To Growth
1.74
2.14
1.03
0.76
2.21
1.69
2.92
0.77
1.61
3.17
Price To Sales
7.13
3.9
1.85
0.17
1.75
5.1
7.1
2.98
0.22
4.46
Net Income
1.4 B
1.02 B
1.36 B
1.19 B
2.15 B
434 M
869.19 M
1.68 B
1.57 B
1.44 B
Earnings Per Share
10.12
2.1
7.62
10.89
4.55
4.43
42.01
6.43
7.09
0.45
Shares Owned By Insiders
0.5
0.14
0.99
0.2
0.27
0.1
0.44
0.38
0.26
0.014
Revenue
5.15 B
9.91 B
16.31 B
129.66 B
20.62 B
6.95 B
4.03 B
21.84 B
222.58 B
11.23 B
Working Capital
2.49 B
4.03 B
(1.13 B)
366.27 M
3.4 B
2.25 B
164.55 M
942 M
(2.52 B)
(94 M)
Cash And Equivalents
1.21 B
1.03 B
1.98 B
2.22 B
N/A
1.79 B
66.89 M
641 M
3.87 B
684 M
Cash Per Share
1.87
2.1
7.32
143.73
N/A
3.57
5.48
9.02
13.32
0.29
Gross Profit
3.32 B
5.66 B
5.43 B
18.85 B
8.25 B
3.64 B
2.39 B
10.23 B
9.04 B
7 B
Day Typical Price
249.59
79.15
165.17
177.04
78.38
124.96
1359.14
179.06
219.32
11.15
Accumulation Distribution
71412.68
39747.56
517769.0
206482.0
152880.0
187503.0
7345.3
127580.0
212858.0
97488.86
Market Facilitation Index
0.0
0.0
0.0
0.0
0.0
0.0
4.0E-4
0.0
0.0
N/A
Daily Balance Of Power
(1.13)
(0.32)
(0.62)
0.3038
(0.17)
(0.50)
(0.55)
(0.46)
(0.60)
0.8571
Period Momentum Indicator
(13.29)
(0.84)
(8.33)
3.43
(0.55)
(4.02)
(34.73)
(2.81)
(9.19)
0.12
Rate Of Daily Change
0.95
0.99
0.95
1.02
0.99
0.97
0.98
0.98
0.96
1.01
Day Median Price
251.52
79.46
163.33
176.15
78.25
125.0
1359.75
179.69
221.45
11.15
Price Action Indicator
(12.43)
(1.33)
1.35
4.4
0.13
(2.13)
(19.19)
(3.28)
(10.98)
0.07
Coefficient Of Variation
6415.76
4977.76
(670.21)
(794.53)
1388.0
(726.10)
(3,429)
576.15
1780.6
480.22
Mean Deviation
1.21
1.09
1.66
2.12
1.48
1.25
1.14
1.19
1.08
0.975
Jensen Alpha
(0.04)
(0.03)
(0.51)
(0.56)
0.0553
(0.33)
(0.12)
0.2139
0.1079
0.2367
Total Risk Alpha
(0.13)
(0.11)
(0.64)
(0.76)
(0.04)
(0.38)
(0.18)
0.1303
(0.07)
0.1391
Sortino Ratio
(0.03)
(0.04)
N/A
N/A
0.0302
N/A
N/A
0.1942
0.0137
0.1591
Downside Variance
3.42
1.41
N/A
N/A
3.52
N/A
N/A
1.07
2.47
1.22
Standard Deviation
1.66
1.45
2.68
3.54
1.91
1.66
1.47
1.62
1.82
1.23
Kurtosis
1.65
1.1
7.8
17.28
(0.20)
0.2675
0.3106
2.34
12.67
(0.11)
Potential Upside
2.12
2.6
3.3
3.79
3.38
2.9
2.51
3.22
1.94
2.76
Treynor Ratio
0.019
0.0261
(0.28)
(0.32)
0.1251
(0.18)
(0.05)
0.3329
(0.42)
1.82
Maximum Drawdown
9.12
7.05
15.97
27.31
7.77
7.85
7.69
7.13
12.26
5.4
Variance
2.75
2.11
7.2
12.56
3.64
2.74
2.16
2.63
3.32
1.51
Market Risk Adjusted Performance
0.029
0.0361
(0.27)
(0.31)
0.1351
(0.17)
(0.04)
0.3429
(0.41)
1.83
Risk Adjusted Performance
0.0178
0.0207
(0.11)
(0.09)
0.0643
(0.11)
(0.02)
0.1459
0.0511
0.1725
Skewness
(0.44)
0.9129
(2.17)
(3.10)
0.1982
0.417
0.1659
1.44
1.83
0.2794
Semi Deviation
1.78
1.16
N/A
N/A
1.74
N/A
N/A
0.73
1.44
0.8278
Information Ratio
(0.03)
(0.04)
(0.18)
(0.15)
0.0297
(0.19)
(0.08)
0.1238
0.0118
0.1426
Value At Risk
(2.54)
(1.98)
(4.70)
(5.40)
(2.77)
(2.73)
(2.37)
(1.77)
(2.43)
(1.65)
Expected Short fall
(1.14)
(1.26)
N/A
N/A
(1.50)
N/A
N/A
(1.50)
(1.18)
(1.12)
Downside Deviation
1.85
1.19
N/A
N/A
1.88
N/A
N/A
1.03
1.57
1.1
Semi Variance
3.15
1.34
N/A
N/A
3.01
N/A
N/A
0.5329
2.08
0.6852

ResMed Competition Performance Charts

Five steps to successful analysis of ResMed Competition

ResMed's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by ResMed Inc in relation to its competition. ResMed's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of ResMed in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact ResMed's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to ResMed Inc, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your ResMed position

In addition to having ResMed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run ISP Thematic Idea Now

ISP
ISP Theme
Internet Service Providers (ISP) companies and IT providers specializing in internet technologies. The ISP theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize ISP Theme or any other thematic opportunities.
View All  Next Launch
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:
How To Invest In ResMed
Details
Is ResMed Stock a good investment?
Details
What is ResMed's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Will Health Care Equipment & Supplies sector continue expanding? Could ResMed diversify its offerings? Factors like these will boost the valuation of ResMed. Anticipated expansion of ResMed directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every ResMed data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
ResMed Inc's market price often diverges from its book value, the accounting figure shown on ResMed's balance sheet. Smart investors calculate ResMed's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since ResMed's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
It's important to distinguish between ResMed's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ResMed should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY